Two-Stage Fermentation for Disulfide Proteins in E. coli

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

E. coli's reducing cytoplasmic environment hampers the soluble expression of proteins with cysteine residues, leading to misfolding and aggregation due to disulfide bond reduction, and previous strain modifications either induce toxicity or require specialized growth conditions.

Innovation Solution

A two-stage fermentation approach is employed to dynamically control the cytoplasmic redox state by maintaining a reducing environment during growth and shifting to an oxidative environment for protein production, utilizing chromosomal deletions and conditional overexpression of disulfide bond enzymes like dsbC and evr1p to facilitate proper folding of heterologous proteins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If constitutive oxidative stress is applied to improve disulfide bond formation, then protein folding is improved, but growth rate decreases and expression conditions are limited

Engineering Contradiction:
Improveprotein foldingVSAvoidgrowth rate
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent implements dynamic control of cytoplasmic redox state by transitioning from a reducing environment during growth phase to an oxidative environment during production phase. This is achieved through conditional expression of reductase enzymes (trxB, gor) using inducible promoters, allowing the system to adapt redox conditions to different physiological stages rather than maintaining constitutive oxidation throughout

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent divides the fermentation process into distinct growth phase and production phase, with each phase having optimized redox conditions. The growth phase maintains reducing conditions for cell proliferation, while the production phase switches to oxidative conditions for disulfide bond formation, allowing independent optimization of each phase without mutual interference

Inventive Principle:
Principle #1Segmentation

2Reliability

If reductase deletions are made to increase oxidative potential, then disulfide bond formation is improved, but toxicity increases and growth is slowed

Engineering Contradiction:
Improvedisulfide bond formationVSAvoidtoxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

Instead of completely deleting reductase genes, the patent uses conditional expression control to dynamically adjust reductase activity levels. The reductase enzymes are expressed only when needed (during phase transition) rather than constitutively, changing the temporal parameter of enzyme availability to achieve oxidative conditions without permanent genetic damage or toxicity

Inventive Principle:
Principle #35Parameter changes

3Reliability

If specialized growth conditions are applied to limit oxidative stress, then cell viability is maintained, but expression efficiency decreases

Engineering Contradiction:
Improvecell viabilityVSAvoidexpression efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent dynamically switches redox conditions between growth and production phases rather than maintaining specialized conditions throughout. During growth, standard conditions maintain viability; during production, induced oxidative conditions maximize expression efficiency, eliminating the need for continuous specialized conditions that would limit overall productivity

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables robust and scalable expression of disulfide-containing proteins, improving their solubility and reducing toxicity, while maintaining exponential growth and oxidative conditions for proper folding, as demonstrated with proteins like human hyaluronidase-I and nanobodies.

Implementation Method 1

maintains a reducing cytosolic environment that is comparable to the reducing cytosolic environment of a microorganism lacking genetic modifications

Methodology Applied
Scientific EffectRedox reactions: Redox Reactions

Implementation Method 2

the synthetic metabolic valve(s) resulting in a shift to an oxidative cytosolic environment, and inducing expression or overexpression of the heterologous protein to result in proper folding of the heterologous protein product in an oxidative environment

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

dsbC isomerizes disulfide bonds to improve correct folding when multiple disulfide bonds are present

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 4

evr1p catalyzes cysteine oxidation and dsbC isomerizes disulfide bonds to improve correct folding when multiple disulfide bonds are present

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20240182912A1Two-stage dynamic control over redox state improves cystolic expression of disulfide containing proeteins in e. coli
Publication Date: 2024.06.06 DUKE UNIV
  • US20240182912A1 patent drawing
  • US20240182912A1 patent drawing
  • US20240182912A1 patent drawing

AI summary

Methods and microorganism for expression of a protein requiring at least one disulfide bond for proper folding of the protein are described. The biofermentation methods comprise growth of a microorganism that may conditionally expressing the protein in addition to at least one synthetic metabolic valve designed to regulate of at least one enzyme effective for altering the redox characteristics of the cytosolic environment of the genetically modified microorganism. In a product producing step of the method, an oxidative cytosolic environment is conditionally provided.